Data is valuable for Kaiser Permanente in significantly improving diabetes treatment, identifying osteoporosis patients, and finding data that showed VIOXX was problematic. Continuous research uses data sources like Medcom, clinical databases, NIP, radiology images, and LPR/patient indexes to power tools like patient panel support, clinical dashboards, best practices, and population research. More involvement is wanted from FMK.